These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24948569)

  • 41. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
    Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CRT plus ICD in congestive heart failure. Use of cardiac resynchronization therapy and an implantable cardioverter-defibrillator in heart failure patients with abnormal left ventricular dysfunction.
    Aronow WS
    Geriatrics; 2005 Feb; 60(2):24, 26-8. PubMed ID: 15742919
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Prevention of sudden death in heart failure patients: cardiac resynchronization therapy with or without defibrillation back-up].
    Pedretti RF; Laporta A; Masnaghetti S; Raimondo R; Salerno M; Santoro F; Vaninetti R
    G Ital Cardiol (Rome); 2010 Oct; 11(10 Suppl 1):134S-136S. PubMed ID: 21416844
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiac resynchronization therapy for prevention of heart failure events in elderly patients with left ventricular dysfunction.
    Dotsenko O; Barsheshet A; Huang DT
    Expert Rev Cardiovasc Ther; 2012 Oct; 10(10):1319-27. PubMed ID: 23190070
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiac resynchronization therapy: what? Who? When? How?
    Cuculich PS; Joseph S
    Am J Med; 2011 Sep; 124(9):813-5. PubMed ID: 21854888
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiac resynchronization therapy with or without an implantable defibrillator: only indicated when everything else has failed?
    Ghosh J; Kaye G; Cleland JG
    Card Electrophysiol Rev; 2003 Dec; 7(4):421-9. PubMed ID: 15071268
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiac resynchronization therapy: a review of CRT-D versus CRT-P.
    Stabile G; Iuliano A; Turco P; Ciardiello C; De Simone A
    Future Cardiol; 2009 Nov; 5(6):567-72. PubMed ID: 19886783
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Change in indication for cardiac resynchronization therapy?
    Lawin D; Stellbrink C
    Eur J Cardiothorac Surg; 2019 Jun; 55(Suppl 1):i11-i16. PubMed ID: 31106336
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiac resynchronization therapy in asymptomatic or mildly symptomatic heart failure patients in relation to etiology: results from the REVERSE (REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction) study.
    Linde C; Abraham WT; Gold MR; Daubert C;
    J Am Coll Cardiol; 2010 Nov; 56(22):1826-31. PubMed ID: 21087711
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of QRS morphology and duration on outcomes after cardiac resynchronization therapy: Results from the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT).
    Birnie DH; Ha A; Higginson L; Sidhu K; Green M; Philippon F; Thibault B; Wells G; Tang A
    Circ Heart Fail; 2013 Nov; 6(6):1190-8. PubMed ID: 23995437
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Device therapy in patients with heart failure and advanced age: too much too late?
    Cutro R; Rich MW; Hauptman PJ
    Int J Cardiol; 2012 Feb; 155(1):52-5. PubMed ID: 21342708
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiac resynchronization therapy: from treatment to prevention.
    Leclercq C; Singh JP
    Eur Heart J; 2011 Jul; 32(13):1580-2. PubMed ID: 21324935
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of metoprolol versus carvedilol on outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy).
    Ruwald MH; Ruwald AC; Jons C; Alexis J; McNitt S; Zareba W; Moss AJ
    J Am Coll Cardiol; 2013 Apr; 61(14):1518-26. PubMed ID: 23500269
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Device Management in Heart Failure.
    Angel BG; Saltzman H; Kusmirek LS
    Curr Cardiol Rep; 2017 Sep; 19(11):114. PubMed ID: 28948481
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian Registry.
    Morani G; Gasparini M; Zanon F; Casali E; Spotti A; Reggiani A; Bertaglia E; Solimene F; Molon G; Accogli M; Tommasi C; Paoletti Perini A; Ciardiello C; Padeletti L
    Europace; 2013 Sep; 15(9):1273-9. PubMed ID: 23439866
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The European cardiac resynchronization therapy survey: patient selection and implantation practice vary according to centre volume.
    Bogale N; Priori S; Gitt A; Alings M; Linde C; Dickstein K;
    Europace; 2011 Oct; 13(10):1445-53. PubMed ID: 21712274
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades.
    Bogale N; Witte K; Priori S; Cleland J; Auricchio A; Gadler F; Gitt A; Limbourg T; Linde C; Dickstein K;
    Eur J Heart Fail; 2011 Sep; 13(9):974-83. PubMed ID: 21771823
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy in Older Adults With Heart Failure.
    Sandhu A; Levy A; Varosy PD; Matlock D
    J Am Geriatr Soc; 2019 Oct; 67(10):2193-2199. PubMed ID: 31403714
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Implantation and patient profiles for pacemakers and cardioverter-defibrillators in France (2008-2009).
    Tuppin P; Neumann A; Marijon E; de Peretti C; Weill A; Ricordeau P; Danchin N; Allemand H
    Arch Cardiovasc Dis; 2011 May; 104(5):332-42. PubMed ID: 21693370
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mortality reduction of cardiac resynchronization and implantable cardioverter-defibrillator therapy in heart failure: an updated meta-analysis. Does recent evidence change the standard of care?
    Bertoldi EG; Polanczyk CA; Cunha V; Ziegelmann PK; Beck-da-Silva L; Rohde LE
    J Card Fail; 2011 Oct; 17(10):860-6. PubMed ID: 21962425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.